Synonyms: CBPD409 | compound 25 [PMID: 38530938]
Compound class:
Synthetic organic
Comment: CBPD-409 is an orally bioactive PROTAC degrader that targets the CBP (CREB binding protein) and p300 (E1A binding protein p300) proteins [1]. It binds to the target proteins using a GNE-049-derived moiety, and a thalidomide ligand is used to interact with the cereblon E3 ubiquitin ligase.
CBP and p300 are bromodomain and histone acetyltransferase (HAT) domain-containing proteins that act as androgen receptor transcriptional coactivators. CBPD-409 was designed to disrupt CBP/p300-induced androgen receptor expression in prostate cancers. |
|
Bioactivity Comments |
CBP/p300 degradation with DC50 0.2-0.4 nM in prostate cancer cell lines; nanomolar antiproliferative potency in AR+ve prostate cancer cell lines, with anti-tumour efficacy in the mouse VCaP xenograft model following oral administration [1]. |
Selectivity at other protein targets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|